AGTRAP and metabolic dysfunction-associated steatotic liver disease: In summary, although there are some limitations to the current study, we provide basic medical evidence to support the hypothesis that SAM positively regulates ATRAP in NAFLD by maintaining its mRNA nucleocytoplasmic shuttling.